CVE-2020-5625

Description

Cross-site scripting vulnerability in XooNIps 3.48 and earlier allows remote attackers to inject an arbitrary script via unspecified vectors.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.43%
Vendor Advisory osdn.jp
Affected: Neuroinformatics Unit, Integrative Computational Brain Science Collaboration Division, RIKEN Center for Brain Science XooNIps
Published at:
Updated at:

References

Link Tags
https://xoonips.osdn.jp/ product
https://xoonips.osdn.jp/modules/news/index.php?page=article&storyid=12 release notes vendor advisory
https://jvn.jp/en/jp/JVN40725650/index.html third party advisory

Frequently Asked Questions

What is the severity of CVE-2020-5625?
CVE-2020-5625 has been scored as a medium severity vulnerability.
How to fix CVE-2020-5625?
To fix CVE-2020-5625, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-5625 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-5625 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-5625?
CVE-2020-5625 affects Neuroinformatics Unit, Integrative Computational Brain Science Collaboration Division, RIKEN Center for Brain Science XooNIps.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.